Vistin Pharma ASA (LON:0RAM)
21.35
+1.15 (5.69%)
At close: Jan 26, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 72.73 million as of February 12, 2026. Its market cap has decreased by -1.27% in one year.
Market Cap
72.73M
Enterprise Value
74.22M
Revenue
33.91M
Ranking
n/a
PE Ratio
12.51
Stock Price
21.35
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 26.81M to 72.73M, an increase of 171.23%. That is a compound annual growth rate of 9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 71.96M | 5.50% |
| Dec 30, 2025 | 68.21M | -7.63% |
| Dec 30, 2024 | 73.85M | -7.68% |
| Dec 29, 2023 | 79.99M | 35.53% |
| Dec 30, 2022 | 59.02M | -18.34% |
| Dec 30, 2021 | 72.28M | 8.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EJF Investments | 73.77M |
| Home Reit | 71.94M |
| Hansard Global | 71.65M |
| Watkin Jones | 70.83M |
| Braemar | 69.01M |
| Fevara | 68.85M |
| Oxford Metrics | 67.03M |
| Blackfinch Spring VCT | 65.58M |